Legislation on the Roles of the Pharmacist and Pharmacy in the Revision of the Pharmaceutical and Medical Device Act and the Pharmacists Act in Japan.
Aging society
Integrated community care system
Pharmaceutical care
Pharmacist
Pharmacy
Journal
Therapeutic innovation & regulatory science
ISSN: 2168-4804
Titre abrégé: Ther Innov Regul Sci
Pays: Switzerland
ID NLM: 101597411
Informations de publication
Date de publication:
03 2021
03 2021
Historique:
received:
05
06
2020
accepted:
28
08
2020
pubmed:
13
9
2020
medline:
2
6
2021
entrez:
12
9
2020
Statut:
ppublish
Résumé
Japan's rapidly aging population has prompted a change in the country's pharmaceutical care framework from a drug-oriented to a patient-oriented approach. Pharmacies and pharmacists are expected to play central roles in this new patient-oriented approach by reconciling medication and managing polypharmacy, conducting home visits, and providing care to patients in collaboration with local clinics and hospitals. These additional roles are expected to lead to a reduction in the prevalence of adverse effects and improve the quality of life of patients in Japan's aging society. To promote patient-oriented care by pharmacists, these additional roles were legislated in a revision of the Japanese Pharmaceutical and Medical Device Act and other related Act in December 2019. Here, we overview how the revisions affect pharmacies, pharmacists, medical institutions, and outpatients.
Identifiants
pubmed: 32918260
doi: 10.1007/s43441-020-00215-2
pii: 10.1007/s43441-020-00215-2
doi:
Substances chimiques
Pharmaceutical Preparations
0
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
304-308Références
A report of the National Institute of Population and Social Security Research on Population and Social Security 2019 in Japan, IPSS Research Report No. 85, July 26, 2019.
A report of the National Institute of Population and Social Security Research on Regional Population Projections 2018 for Japan, https://www.ipss.go.jp/pp-shicyoson/j/shicyoson18/t-page.asp (Japanese)
Vision of Pharmacy Useful for Patients, The Ministry of Health, Labour and Welfare, Oct 23, 2015. Notification 1023 No. 3 of 2015 of the PFSB/GAD (Japanese)
Nakai K, Kawahara A, Kamei M, Kurata N. Evaluation of new reimbursement fee for care of pharmacist in Japan. Pharm Pharmacol Int J. 2018;6:313–8.
The Pharmacists Act, Act No. 103 of 2013. https://www.japaneselawtranslation.go.jp/law/detail/?id=2596&vm=04&re=01
A report in the Health Sciences Council in MHLW on July 5, 2018. https://www.mhlw.go.jp/stf/newpage_00592.html (Japanese)
Law that partially amends the Pharmaceutical and Medical Device Act and other related Acts. Act No. 63 of 2019. https://www.mhlw.go.jp/content/000489905.pdf (Japanese)
World Health Organ. Primary health care—Now more than ever. World Health Rep., World Health Organ., New York, 2008
A report on revision of the medical payment system of the Central Social Insurance Medical Council on November 2017. https://www.mhlw.go.jp/file/05-Shingikai-12404000-Hokenkyoku-Iryouka/0000184199.pdf (Japanese)
Mair A, Wilson M, Dreischulte T. Addressing the challenge of polypharmacy. Annu Rev Pharmacol Toxicol. 2020;60:661–81.
doi: 10.1146/annurev-pharmtox-010919-023508
Research in pharmacy/pharmacist, in July, 25, 2018. https://www.mhlw.go.jp/content/11121000/000362221.pdf (Japanese)
A report of the medical payment system of the Central Social Insurance Medical Council on November 2018. https://www.mhlw.go.jp/file/05-Shingikai-12404000-Hokenkyoku-Iryouka/0000190472.pdf (Japanese)
A report of the House of Councillors, The National Diet of Japan. https://www.sangiin.go.jp/japanese/annai/chousa/rippou_chousa/backnumber/2019pdf/20190508041.pdf (Japanese)